抗血管生成药物在非小细胞肺癌中的应用及研究进展(5)
[15]Ramlau R，Gorbunova V，Ciuleanu TE，et al.Aflibercept and Docetaxel versus Docetaxel alone after platinum failure in patients with advanced or metastatic non-small-cell lung cancer： a randomized， controlled phase III trial[J].J Clin Oncol，2012，30(29)：3640-3647.[16]Chen H，Modiano MR，Neal JW，et al.A phase II multicentre study of ziv-aflibercept in combination with cisplatin and pemetrexed in patients with previously untreated advanced/metastatic non-squamous non-small cell lung cancer[J].Br J Cancer ......
您现在查看是摘要页，全文长 2825 字符。